BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16213500)

  • 21. An A to U transversion at position 1067 of 23 S rRNA from Escherichia coli impairs EF-Tu and EF-G function.
    Saarma U; Remme J; Ehrenberg M; Bilgin N
    J Mol Biol; 1997 Sep; 272(3):327-35. PubMed ID: 9325093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
    Anborgh PH; Okamura S; Parmeggiani A
    Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed release of inorganic phosphate from elongation factor Tu following GTP hydrolysis on the ribosome.
    Kothe U; Rodnina MV
    Biochemistry; 2006 Oct; 45(42):12767-74. PubMed ID: 17042495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [GTPases of prokaryotic translational apparatus].
    Hauryliuk VV
    Mol Biol (Mosk); 2006; 40(5):769-83. PubMed ID: 17086977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visualization of elongation factor Tu on the Escherichia coli ribosome.
    Stark H; Rodnina MV; Rinke-Appel J; Brimacombe R; Wintermeyer W; van Heel M
    Nature; 1997 Sep; 389(6649):403-6. PubMed ID: 9311785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
    Navratil T; Spremulli LL
    Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcus aureus elongation factor G--structure and analysis of a target for fusidic acid.
    Chen Y; Koripella RK; Sanyal S; Selmer M
    FEBS J; 2010 Sep; 277(18):3789-803. PubMed ID: 20718859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation factor IF2, thiostrepton and micrococcin prevent the binding of elongation factor G to the Escherichia coli ribosome.
    Cameron DM; Thompson J; March PE; Dahlberg AE
    J Mol Biol; 2002 May; 319(1):27-35. PubMed ID: 12051934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics of ribosomal elongation factors G and Tu.
    Kulczycka K; Długosz M; Trylska J
    Eur Biophys J; 2011 Mar; 40(3):289-303. PubMed ID: 21152913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
    Cetin R; Anborgh PH; Cool RH; Parmeggiani A
    Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of active elongation factor Tu reveals major domain rearrangements.
    Berchtold H; Reshetnikova L; Reiser CO; Schirmer NK; Sprinzl M; Hilgenfeld R
    Nature; 1993 Sep; 365(6442):126-32. PubMed ID: 8371755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro selected RNA molecules that bind to elongation factor Tu.
    Hornung V; Hofmann HP; Sprinzl M
    Biochemistry; 1998 May; 37(20):7260-7. PubMed ID: 9585539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
    Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
    J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GTPase activation of elongation factors Tu and G on the ribosome.
    Mohr D; Wintermeyer W; Rodnina MV
    Biochemistry; 2002 Oct; 41(41):12520-8. PubMed ID: 12369843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of intact elongation factor EF-Tu from Escherichia coli in GDP conformation at 2.05 A resolution.
    Song H; Parsons MR; Rowsell S; Leonard G; Phillips SE
    J Mol Biol; 1999 Jan; 285(3):1245-56. PubMed ID: 9918724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The conformational properties of elongation factor G and the mechanism of translocation.
    Czworkowski J; Moore PB
    Biochemistry; 1997 Aug; 36(33):10327-34. PubMed ID: 9254632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible evolution of factors involved in protein biosynthesis.
    Nyborg J
    Acta Biochim Pol; 1998; 45(4):883-94. PubMed ID: 10397336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elongation factors Tu and G change their conformation on interaction with ribosomes.
    Bubunenko MG; Gudkov AT
    Biomed Sci; 1990 Feb; 1(2):127-32. PubMed ID: 2102775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The location and the significance of a cross-link between the sarcin/ricin domain of ribosomal RNA and the elongation factor-G.
    Chan YL; Correll CC; Wool IG
    J Mol Biol; 2004 Mar; 337(2):263-72. PubMed ID: 15003445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of tetracyclines to elongation factor Tu, the Tet repressor, and the ribosome: a molecular dynamics simulation study.
    Aleksandrov A; Simonson T
    Biochemistry; 2008 Dec; 47(51):13594-603. PubMed ID: 19032078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.